Clinical trial
CorMatrix® Cor™ TRICUSPID ECM® Valve Replacement Study
NCT05742906 is registered in ClinicalTrials.gov with Corvivo Cardiovascular, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CorMatrix® Cor™ TRICUSPID ECM® Valve Replacement Study
- Lead sponsor
- Corvivo Cardiovascular, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 10, 2022
- Completion date
- December 31, 2026
- Enrollment
- 92 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
tricuspid valve disease, tricuspid valve insufficiency